378.23美元5.21(1.36%)
2023/06/07更新
績效 / 1月1.92%
3月3.71%
1年5.76%
晨星評等 - 1.現金0.00%
- 2.股票37.62%
- 3.債券0.00%
- 4.其他62.38%
- 1.美國62.38%
- 2.歐洲不包含歐元區22.89%
- 3.日本5.51%
- 4.英國4.48%
- 5.歐元區3.04%
- 1.健康護理96.49%
- 2.工業2.18%
- 3.基本物料0.85%
- 4.防守性消費0.48%
- 1.UnitedHealth Group Inc8.59%
- 2.Novo Nordisk A/S Class B8.13%
- 3.Roche Holding AG6.95%
- 4.Amgen Inc5.26%
- 5.Elevance Health Inc5.09%
- 6.Vertex Pharmaceuticals Inc5.07%
- 7.Eli Lilly and Co5.01%
- 8.Gilead Sciences Inc5.01%
- 9.Regeneron Pharmaceuticals Inc4.51%
- 10.GSK PLC4.48%
- 1.現金0.00%
- 2.股票37.62%
- 3.債券0.00%
- 4.其他62.38%
- 1.健康護理96.49%
- 2.工業2.18%
- 3.基本物料0.85%
- 4.防守性消費0.48%
- 1.美國62.38%
- 2.歐洲不包含歐元區22.89%
- 3.日本5.51%
- 4.英國4.48%
- 5.歐元區3.04%
- 1.UnitedHealth Group Inc8.59%
- 2.Novo Nordisk A/S Class B8.13%
- 3.Roche Holding AG6.95%
- 4.Amgen Inc5.26%
- 5.Elevance Health Inc5.09%
- 6.Vertex Pharmaceuticals Inc5.07%
- 7.Eli Lilly and Co5.01%
- 8.Gilead Sciences Inc5.01%
- 9.Regeneron Pharmaceuticals Inc4.51%
- 10.GSK PLC4.48%